Do prostate cancer patients at risk of pelvic lymph-node metastasis benefit from pelvic radiation?

被引：0
|
作者：
Palapattu, G. S. [1 ]
Messing, E. M. [1 ]
机构：
[1] Univ Rochester, Dept Urol, James P Wilmot Canc Ctr, Sch Med, Rochester, NY 14627 USA
来源：
NATURE CLINICAL PRACTICE UROLOGY | 2006年 / 3卷 / 05期
关键词：
brachytherapy; pelvic radiation; prostate cancer; radiation therapy;
D O I：
10.1038/ncpuro0463
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：258 / 259
页数：2
相关论文
共 50 条
  • [1] Lack of benefit of pelvic radiation in prostate cancer patients with a high risk of positive pelvic lymph nodes treated with high-dose radiation
    Vargas, CE
    Galalae, R
    Demanes, J
    Harsolia, A
    Meldolesi, E
    Nürnberg, N
    Schour, L
    Martinez, A
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (05): : 1474 - 1482
  • [2] The influence of lymph node counts on the detection of pelvic lymph node metastasis in prostate cancer
    Barth, PJ
    Gerharz, EW
    Ramaswamy, A
    Riedmiller, H
    PATHOLOGY RESEARCH AND PRACTICE, 1999, 195 (09) : 633 - 636
  • [3] Radiation therapy for pelvic lymph node metastasis from uterine cervical cancer
    Hata, Masaharu
    Koike, Izumi
    Miyagi, Etsuko
    Numazaki, Reiko
    Asai-Sato, Mikiko
    Kasuya, Takeo
    Kaizu, Hisashi
    Matsui, Tonika
    Hirahara, Fumiki
    Inoue, Tomio
    GYNECOLOGIC ONCOLOGY, 2013, 131 (01) : 99 - 102
  • [4] Pelvic Lymph Node Dissection in Prostate Cancer
    Briganti, Alberto
    Blute, Michael L.
    Eastham, James H.
    Graefen, Markus
    Heidenreich, Axel
    Karnes, Jeffrey R.
    Montorsi, Francesco
    Studer, Urs E.
    EUROPEAN UROLOGY, 2009, 55 (06) : 1251 - 1265
  • [5] Pelvic lymph-node staging with 18F-DCFPyL PET/CT prior to extended pelvic lymph-node dissection in primary prostate cancer - the SALT trial -
    B. H. E. Jansen
    Y. J. L. Bodar
    G. J. C. Zwezerijnen
    D. Meijer
    J. P. van der Voorn
    J. A. Nieuwenhuijzen
    M. Wondergem
    T. A. Roeleveld
    R. Boellaard
    O. S. Hoekstra
    R. J. A. van Moorselaar
    D. E. Oprea-Lager
    A. N. Vis
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 509 - 520
  • [6] Pelvic lymph node dissection in high-risk prostate cancer
    Haiquel, Luciano
    Cathelineau, Xavier
    Sanchez-Salas, Rafael
    Macek, Petr
    Secin, Fernando
    INTERNATIONAL BRAZ J UROL, 2022, 48 (01): : 54 - 66
  • [7] Extended pelvic lymph-node dissection and radiotherapy with curative intent in high-risk lymph-node-positive prostate cancer: a possible curative strategy?
    Al-Amiri, Bashar
    Lundin, Fredrik
    Walden, Mauritz
    SCANDINAVIAN JOURNAL OF UROLOGY, 2018, 52 (02) : 101 - 107
  • [8] Predicting pelvic lymph node involvement in patients with localized prostate cancer
    Ekman, P
    EUROPEAN UROLOGY, 1997, 32 : 60 - 64
  • [9] Pelvic lymph-node staging with18F-DCFPyL PET/CT prior to extended pelvic lymph-node dissection in primary prostate cancer-the SALT trial
    Jansen, B. H. E.
    Bodar, Y. J. L.
    Zwezerijnen, G. J. C.
    Meijer, D.
    van der Voorn, J. P.
    Nieuwenhuijzen, J. A.
    Wondergem, M.
    Roeleveld, T. A.
    Boellaard, R.
    Hoekstra, O. S.
    van Moorselaar, R. J. A.
    Oprea-Lager, D. E.
    Vis, A. N.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (02) : 509 - 520
  • [10] Additional Parameters to the Briganti Nomogram for Predicting Pelvic Lymph Node Metastasis in Prostate Cancer
    Gul, Abdullah
    Ekici, Ozgur
    ARCHIVOS ESPANOLES DE UROLOGIA, 2024, 77 (06): : 614 - 621
12345